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Immune complex induced glomerular lesions in CS sufficient and
deficient mice. The role in the pathogenesis of immune complex—medi-
ated glamerulonephritis of CS or some terminal complement component
dependent upon CS for activation was explored in a congenic strain of
CS sufficient (NSN) and CS deficient (OSN) mice. When these mice
were given daily injections of heterologous protein, horse apoferritin(HAF), there were profound differences between the strains in the
development of glomerulonephritis and renal dysfunction. When NSN
and OSN mice produced low levels of anti-HAF, NSN mice developed
extensive glomerular deposits of HAF and immune reactants and a mild
proliferative glomerulonephritis. In contrast, comparable OSN mice
developed only trace mesangial localization of HAF and no glomerular
lesions by light microscopy. When NSN and OSN mice produced high
levels of anti-HAF, both strains had equivalent glomerular immune
deposits; however, NSN mice developed a severe necrotizing and
crescentic glomerulonephritis, while OSN mice had much less glomer-
ular injury. Compared to OSN mice, these NSN mice also had much
more severe tubulointerstitial injury, and significantly higher serum
creatinine levels. Thus, in this experimental model, the absence of CS
resulted in reduced glomerular immune complex localization when
there were small amounts of circulating immune reactants; and in
markedly reduced glomerular leukocytc influx, necrosis and crescent
formation, when large amounts of immune reactants have localized in
glomeruli. These effects could be mediated by CS (such as CSa) or by
some terminal complement component(s) dependent upon CS for acti-
vation.
Complement is a major mediator of the renal injury and
dysfunction that results from immune complex localization in
glomeruli, either by deposition from the circulation or by in situ
formation. Complement is similarly involved with mediating
immune complex—induced injury in other tissues. In both hu-
mans and experimental animals with immune complex—induced
renal diseases, classical pathway, alternative pathway, and
terminal complement components are often demonstrable
within glomerular immune deposits (1—3). The pathogenetic role
of complement has been investigated in a number of experimen-
tal models of immune—mediated glomerular disease. In nephro-
toxic nephritis of rats, depletion of plasma complement com-
ponents with cobra venom factor prevents development of the
renal injury, due at least in part to abrogated leukocyte
chemotaxis 14, 5]. In a rat model of membranous glomerulopa-
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thy, complement depletion with cobra venom factor has dem-
onstrated a role for complement activation in inducing protein-
uria [6]. In a similar model, rabbits with normal complement
developed proteinuria, but C6-defieient rabbits did not, indicat-
ing an effect of the terminal complement components in medi-
ating glomerular injury 171. These models of membranous
glomerulopathy do not appear to involve leukocytes in their
pathogencsis. In contrast, when rabbits were given a single
dose of antigen and developed immune complex nephritis,
complement depletion did not diminish glomerular injury 18].
Our studies were designed to investigate the role of CS or some
terminal complement component dependent on CS for activa-
tion in the pathogenesis of murine immune complex—mediated
proliferative glomerulonephritis of varying severity, ranging
from mild mesangiopathie changes to severe crescentic glomer-
ulonephritis with extensive leukocyte infiltration.
Glomerulonephritis was induced by the administration of a
heterologous protein, horse apoferritin (HAP) 19, 10] in a
congcnic mouse strain differing in a single gene locus coding for
the presence or absence of CS. This experimental model has
advantages over previously studied models in that: 1) the
problem of variation in strain between experimental and control
animals encountered in C6-defieient rabbit studies is avoided by
using congenie animals; 2) the formation of activated comple-
ment components inherent in the use of cobra venom factor is
prevented; and 3) the leukotaetie and/or membranolytic role of
CS can be evaluated in glomerular lesions of varying severity,
including severe proliferative and ereseentie glomerulonephri-
tis. These studies document a critical role for CS, or some
terminal complement component(s) dependent upon CS for
activation, in the development of immune complex—induced
glomerular inflammation and renal dysfunction.
Methods
B.I0.D2 NSN (CS sufficient) and B.lO.D2 OSN (CS deficient)
male mice were obtained from Jax Laboratory (Bar Harbor,
Maine, USA). Animals were divided into three experimental
groups: Group I animals were five to nine weeks of age at the
time of initial antigen administration. They received a high dose
of antigen 4 mg of HAP (Sigma Chemical Co., St. Louis,
Missouri, USA) in 0.1 ml of physiologic saline injected intra-
peritoneally (i,p.) six days per week (high dose schedule).
Group II mice were four to eight months of age and were given
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Fig. 1. Immunofluorescent localization of HAF in glomeruli was
graded from 0 to 4+ on the basis of intensity and distribution of the
antigen. There was no difference in HAF localization in NSN and OSN
mice in group lb and II who mounted a high—titered antibody response
at four weeks. In Group Ia, NSN mice had significantly more HAF in
their glomeruli than similarly treated OSN animals (P < 0.001).
the same high dose of HAF. Group III mice were five months
old and received a low dose schedule of 1 mg HAF given i.p.
every other day. Injections were continued for two, four, and
six weeks, and the animals sacrificed at these predetermined
intervals. Cage control mice in both five to nine week and four
to eight month animals were sacrificed for study at the six week
time point. Whenever possible, plasma was obtained from the
retroorbital plexus under ether anesthesia in heparinized
Natelson blood collecting tubes (Fisher Scientific, Pittsburgh,
Pennsylvania, USA). The plasma was separated and stored at
—70° until used. Animals were sacrificed by cervical disloca-
tion, the kidneys removed, and processed for light, immunoflu-
orescence, and electron microscopy. For immunofluorescence
microscopy, blocks of tissue were snap frozen in liquid nitro-
gen, embedded in OCT and stored at —70° until sectioned. Four
micrometer sections were stained with fluoresceinated goat
antibodies to mouse IgG, 1gM and C3, and with a rhoda-
mine—labelled goat anti-HAF (Cappel Laboratories, Inc.,
Cochranville, Pennsylvania, USA). Preparations were exam-
ined using a Leitz Orthoplan microscope equipped for incident
light fluorescence microscopy (Leitz, Heerbrugg, Switzerland).
The location of immune deposits (that is, mesangial or capillary
wall) and intensity (0 to 4+) of immunostaining were deter-
mined. Tissues for light microscopy were fixed in B-S solution,
and paraffin sections stained with hematoxylin and eosin.
Glomerular morphologic lesions were scored blindly by both
observers on the basis of the following parameters: 0—no
glomerular lesion; 1+—a segmental hypercellular lesion in
many but not all glomeruli; 2+—extensive hypercellularity
throughout all glomeruli; 3+—a necrotizing lesion defined by
the presence of karyorrhexis; 4+—crescentic nephritis. In all
cases mice with necrotizing lesions also had 2+ hypercellular-
ity, and those with crescentic disease had necrosis and
hypercellularity. Glomerular cell counts were performed on all
tissues. At least five cortical glomeruli sectioned through the
hilus were selected randomly, the number of nuclei counted and
a mean number of cells per glomerulus determined for each
animal. Results are expressed as the group mean which is the
mean of the mean number of glomerular cells for each animal.
Samples for electron microscopy were fixed in glutaral-
dehyde, followed by post-fixation in osmium tetroxide, and
embedded in Polybed 812 as previously described [9, 10].
Sections were doubly stained with uranyl acetate and lead
citrate. Ultrastructural examination was carried out with a
JEOL JEM-T7 transmission electron microscope (Jeol Ltd.,
Tokyo, Japan). Special attention was paid to the quantity and
location of glomerular electron—dense deposits.
Quantitative assay for plasma anti-HAF
An ELISA was established to measure plasma antibodies to
HAF. Plasma samples obtained at the time of sacrifice were
separated and stored at —70°. The ELISA was performed in 96
well microtiter plates (Costar, Cambridge, Massachusetts,
USA) based on a previously described method [1]. The wells
were coated with 0.1 mg/ml HAF in phosphate buffered saline
(PBS) (0.15 M NaC1, 0.01 M NaH2PO4, pH 7.4). After one hour
incubation at room temperature, then at 4°overnight, the wells
were washed thrice with PBS—0.5% Tween—20 (Sigma). Non-
specific binding of protein to the wells was prevented by
incubation for one hour with 5% bovine serum albumin (Sigma).
After another wash, a standard dilution of plasma was added for
one hour at room temperature, the wells were washed as
before, and a dilution of peroxidase labelled goat anti-mouse
IgG (y and chain specific) (Tago, Inc., Burlingame, Califor-
nia, USA) was added for 20 minutes. The substrate for the
reaction was a solution of 0.04% ortho-phenylendiamine
dihydrochloride (Eastman Kodak Co, Rochester, New York) in
a solution of citrate phosphate (0.5 M citric acid and 0.1 M
NaH2PO4, pH 5.0) with 0.012% hydrogen peroxide (Fisher
Scientific, Pittsburgh, Pennsylvania, USA). The optical density
was read at 450 nm at 20 minutes with a Titertek multiscan
(Flow Laboratories, Helsinki, Finland). All samples were run in
duplicate. Test samples were compared with control mouse
plasma and with a standard pool of plasma obtained from
hyperimmunized BALB/C mice. Results are expressed as per-
centage of the value of the hyperimmune pool.
Measurement of hemolytic activity and serum creatinine
levels
To identify NSN and OSN mice, a sensitive total hemolytic
assay (CH5O) was performed. A modification of the standard
CH5O [111 assay was required in that sheep red blood cells were
sensitized (EA) with a 1:75 dilution of hemolysin, and washed in
cold gelatin veronal buffered saline. Mouse serum was har-
vested from the retroorbital plexus and immediately placed on
ice. After separation, the serum was added to EA within 30
minutes of the time that the hemolysin had been added.
B. 10.D2.OSN sera had negligible hemolytic activity, whereas
B. l0.D2 NSN sera consistently demonstrated hemolytic activ-
ity from 50 to 100% of the complete lysis control sample. Serum
creatinine levels were measured using an adaptation of the
autoanalyzer method [121.
Statistical analysis
For these data, several comparisons were carried out in order
to ascertain whether strain or group differences existed. For
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Fig. 2. Five to nine—week—old NSN mice given 4 mg HAF daily for six weeks who mounted low liter antibody responses (Group ía) had more
staining for HAF in their glomeruli (A) than similarly treated OSN mice (B). Staining for IgG, 1gM and C3 was similarly more intense in NSN than
OSN mice. NSN mice in this group had 2+ proliferative mesangial lesions (C), whereas OSN mice did not have a morphologic abnormality (D).
All photomicrographs X600, A and B anti-HAF immunofluorescence microscopy, C and D hematoxylin and eosin.
continuous variables, such as serum creatinine, antibody levels
and glomerular cell counts, an analysis of variance was per-
formed to simultaneously analyze the data from all four groups.
T-tests were then utilized to assess the significance of differ-
ences between Groups Ia vs. lb. vs. II, vs. III and between
NSN and OSN mice for any given group. For discrete ordinal
variables, such as glomerular lesions, extent of tubulointer-
stitial infiltrate or of immunofluorescent antigen localization,
the non-parametic analog of the t-test, the Wilcoxon rank—sum
test, was utilized in assessing the significance of strain differ-
ences in each group. Because so many tests were performed, a
Bonferroni correction was made to control the significance level
of the tests. In this correction, the alpha level (0.05 for the tests)
is divided by the number of tests being made.
In order to assess the relationship between the morphologic
composite score and serum creatinine for Group II, a linear
regression model was fit to these data. The significance of the
departure from zero of the coefficient of 0.82 was carried out
using the F statistic.
The data management and analysis of these data were carried
out utilizing the Statistical Analysis System [131.
Results
Group Ia, 5—9 week old mice with low titer antibody
production
In two separate experiments, a total of 40 five to nine week
old mice were given 4 mg HAF six days per week. The results
from these two experiments were similar and the data were
pooled.
Four NSN and four OSN animals were sacrificed at two
weeks. Immunofluorescence microscopy revealed minimal
staining of the tissue by antisera to IgG, 1gM, C3 or HAF. Light
microscopic examination did not reveal glomerular or intersti-
tial lesions.
Eight NSN and eight OSN animals were sacrificed at four
weeks, and the same number of animals at six weeks. No
apparent morphologic or immunohistopathologic differences
were noted between the four and six week groups, so the
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Fig. 3. Light microscopic morphologic lesions were graded as follows:
0—no lesion; 1+—mild mesangial proliferation in some glomeruli; 2+—
proliferative response in all glomeruli; 3+—necrotizing lesions; 4+—
crescentic glomerulonephritis. Five to nine—week—old mice given high
dose HAF mounted either a low titered antibody response (Ia) or high
titers of anti-HAF (Ib). Group II animals were also given high dose
HAF but were four to eight months old; Group III animals were five
months old and received 1 mg HAF every other day. There were
significant differences between NSN and OSN lesions in Ia, lb and III
(P < 0.01) and Group II (P < 0.001).
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Fig. 4. Tubulointerstitial lesions were scored. on the basis of the
percentage of cortex infiltrated with inflammatory cells. Grading scale
is: 0—no apparent tubulointerstitial infiltrates; 1+—less than 25%;
2+—25 to 50%; 3+—50 to 75%; 4+—greater than 75% of cortex
involved. While there was no statistically significant difference between
the degree of infiltration between NSN and OSN mice in groups Ia and
Lb there was a difference between NSN and OSN mice in Group II (P
<0.01).
pathologic data from these animals were combined. By im-
munofluorescence microscopy, 14 of 16 NSN animals had 3 to
4+ mesangial localization of HAF (Figs. 1 and 2). In contrast,
14 of 16 OSN animals had significantly less mesangial HAF
deposition (P < 0.001). IgG and C3 localization was present
with similar intensity and distribution to that of HAF, while
1gM was deposited to a lesser extent. In those NSN animals
with extensive mesangial immunoreactant localization, granular
deposits of HAF, IgG, and C3 were also observed along the
capillary walls.
Light microscopic examination of Group la did not demon-
NSN OSN
Group Ia
2 week 20.5 73N=4 17.9 7.8N=4
4 week 22.4 11.4N=8 21.2 7.0N=8
6 week 18.3 6.5N=8 19.3 11.2N=8
Group lb
4 week 41.1 8.2N=8 34.8 9.3N=8
Group II
2 week 57.4 12.5N=4 53.2 20.2N=4
4 week 56.1 26.8
N=14
36.2 19.3
N=14
Group III
2 week 78.5 41.2N=5 64.8 0.7N=5
4 week 27.9 20N=7 36.8 20N=7
strate morphologic lesions in the OSN group (Figs. 2D and 3).
In comparison, a significant number of NSN animals (seven of
16) (P < 0.01) had a 1 to 2+ proliferative glomerular lesion
(Figs. 2C and 3), while one NSN mouse had crescentic
nephritis. The mean glomerular cell count for NSN mice was 48
2 (mean SEM) (cells per glomerulus) (N = 16) and was
significantly higher than the mean for OSN mice who had 41
2 cells per glomerulus (N = 16) (P < 0.05). Moreover, five of 16
NSN mice had tubulointerstitial inflammatory cell infiltrates
(Fig. 4). On electron microscopy, NSN mice had prominant
mesangial as well as occasional subendothelial and subepithelial
capillary wall electron dense deposits. OSN mice had only rare
mesangial deposits.
Low levels of anti-HAF antibody production were observed
in Group la mice after HAP injection for two, four and six
weeks. At none of these time points was there a difference in
anti-HAF levels between NSN and OSN animals (P > 0.9)
(Table 1). Serum creatinine levels in NSN and OSN mice were
equivalent and no higher than control mice (mean of 0.2 mgldl).
Cage control animals sacrificed at four to six weeks had no
detectable antigen deposition in glomeruli and no more than
trace immunoglobulin and complement localization. The light
microscopic appearance of these control kidneys served as a
reference for analyzing glomerular morphology of mice given
HAF.
Group Ib, five to nine week old mice with high titer antibody
response
Sixteen five to nine—week—old mice divided equally between
NSN and OSN animals were given the high dose antigen
administration schedule. All animals were sacrificed at four
weeks. All of the plasma anti-HAF levels were significantly
higher at four weeks in this group than in Group Ia (P < 0.01)
(Table 1), and equivalent to levels seen in four to eight month
4+ • 6 —
3+ •
2 • • — S
1+ • S S
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Table 1. Plasma anti-HAF levels determined by ELISA after 2, 4 or 6
weeks of immunization
a Expressedas the percentage of the sample value compared with the
anti-HAF level in pooled hyperimmunized control animal plasma
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Fig. 5. There was no immunohistochemical difference in staining for IJAF in four to eight month NSN(A) and OSN (B) mice given 4 mg HAF
daily for six weeks who mounted high—titered antibody responses. However, NSN mice invariably had necrotizing and/or crescentic
glomerulonephritis (C), whereas OSN mice glomeruli were characterized by mesangial matrix expansion (D). The NSN glomerulus in panel C has
karyorrhexis (curved arrow) and a cellular crescent (between the two straight arrows). The OSN glomerulus in panel D has marked matrix
expansion (arrows) corresponding to the massive electron dense deposits seen in Figure 7. All photomicrographs (x600), A and B anti-HAF
immunofluorescence microscopy, C and D hematoxylin and eosin.
old mice (Group II mice). There was no difference in antibody
levels between NSN and OSN mice (P > 0.3). Because of the
significantly different level of immune response, lb mice were
analyzed separately from Ia mice despite the similarity of their
age.
NSN and OSN mice had equivalent glomerular deposition of
immunoglobulin, C3 and HAF as assessed by immunofluores-
cence microscopy. By light microscopy, one NSN mouse had
no glomerular lesion, one had a 2+ proliferative, three had a
necrotizing and three had a crescentic nephritis. Only three
OSN mice had a 1 + proliferative lesion; while the other five
animals had no glomerular morphologic alterations (NSN vs.
OSN, P <0.01). Glomerular cell counts in NSN mice revealed
a mean of 53 2 cells/glomerulus (N = 8), a greater number
than that found in OSN mice who had 28 2 (N = 8, P <
0.001). Thus these NSN mice with a high—titered antibody
response had a proportionally greater degree of glomerular
damage than Group la mice.
Group II, four to eight month old NSN and OSN mice
The effect of HAF administration was explored in older
animals, since the level of CS increases with age in NSN mice
[14]. Four to eight month old animals were administered 4 mg
HAF six days per week. At two weeks, four NSN and four
OSN animals were sacrificed and had similar 3 to 4+ mesangial
deposition of HAF, IgG, 1gM, and C3 by immunofluorescence
microscopy. Rare capillary wall immunoreactant deposition
was seen. All four NSN mice had 3+ necrotizing proliferative
lesions by light microscopy, whereas two OSN animals had a
2+ proliferative lesion and two had no morphologic abnormal-
ity.
Fourteen NSN and fifteen OSN mice were sacrificed at four
to five weeks. Equivalent mesangial deposition of immunoglob-
ulin, C3 and HAF was found in both groups, so that NSN and
OSN animals were immunohistochemically indistinguishable
(Figs. 1 and 5). Substantial capillary wall localization of HAF,
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lation was observed between the pathologic lesion and impair-
ment of renal function (r = 0.82, P < 0.001; Fig. 9). Addition-
ally, the five severely affected OSN animals with composite
histologic scores of 5 or greater had statistically lower
creatinines than similarly affected NSN animals (P <0.05).
Plasma anti-HAF levels (Table 1) were not statistically dif-
ferent between these older NSN and OSN mice at two or four
weeks. However, older mice had significantly higher plasma
antibody levels than Group Ia young mice at two and four
weeks (P < 0.01).
Group III, five month old mice given low dose HAF
Fig. 6. Electron micrograph of a glomerulus from a NSN mouse with
pro4ferative glomerulonephritis showing mononuclear phagocytes with
numerous cytoplasmic phagolysosomes (arrows) (X 7,500).
C3, and IgG was also observed. By light microscopy, a readily
distinguishable difference between CS sufficient and deficient
animals was apparent (Figs. 3 and 5) (P < 0.001). All 14 NSN
mice had diffuse proliferative glomerulonephritis with many
areas of karyorrhexis, and 12 of 14 mice had crescent formation
(Fig. 5). The cellularity of these glomeruli was due to mesangial
cell proliferation as well as an influx of mononuclear leuko-
cytes, best identified by electron microscopy (Fig. 6). Polymor-
phonuclear leukocyte infiltration was rare. In contrast, 10 of 15
OSN mice had glomerular alterations characterized primarily
by matrix expansion rather than cellular proliferation, and had
no areas of necrosis or crescent formation. Five OSN animals
did have areas of necrosis, and four of these had crescentic
disease. The nature of the matrix expansion seen in OSN mice
by light microscopy was resolved on electron microscopy.
Large dense deposits of presumed immune complex material
were observed in the mesangium, subendothelial, and to a
lesser degree subepithelial areas (Fig. 7). The hypercellularity
of the NSN lesion was documented by the difference in mean
glomerular cell counts (NSN: 61 2 cells/glomerulus (N = 14)
vs. OSN: 36 2 cells/glomerulus (N = 15, P < 0.001).
In the tubulointerstitial compartment, 13 of 14 NSN mice had
varying degrees of cellular infiltration, while only five of 15
OSN were similarly affected (Figs. 4 and 8). These five OSN
mice were the same animals with glomerular necrosis and
crescentic lesions. In no animal in any group was there evi-
dence of extraglomerular vascular injury. Cage control NSN
and OSN mice of four to eight months of age did not have
glomerular or interstitial lesions.
A significant difference was observed between the mean
serum creatinine of 0.51 0.04 mgldl (± sEM) in NSN mice and
0.35 0.05 in OSN mice (P < 0.05). Moreover, when the serum
creatinines were compared with a composite morphologic score
(that is, glomerular plus tubulointerstitial score), a close cone-
Previous investigations using this model of glomerulonephri-
tis have demonstrated that glomerular injury is dependent on
the dose of the administered antigen [10]. In view of the
differences in the immunoreactant localization and light micro-
scopic morphology of younger and older mice, we sought to
establish whether a lower antigenic load, when given to older
mice, would magnify NSN and OSN differences. Five—month—
old mice were given 1 mg HAF on alternate days. In both NSN
and OSN mice, five animals were sacrificed at two weeks and
seven at four weeks. At two weeks there was a trend towards an
increase in HAF, IgG, 1gM, and C3 glomerular localization
observed in the mesangial region of NSN when compared to
OSN mice, but this difference was not statistically significant.
By four weeks, however, no differences in antigen localization
were discernable. At two weeks, no morphologic abnormality
was seen by light microscopy in either NSN or OSN mice. At
four weeks, none of the seven OSN mice had developed
glomerular or interstitial alterations; whereas four of seven
NSN had necrotizing lesions and two others had proliferative
changes (Fig. 3). NSN glomeruli had 50 2 cells/glomerulus (N
= 7) compared to OSN glomerular cell counts of 33 2
cells/glomerulus (N = 7, P < 0.001). Plasma anti-HAF levels
were similar in NSN and OSN animals, with higher levels seen
at two weeks than at four weeks (Table 1).
Discussion
In the present study, we evaluated the effects of CS defi-
ciency in a model of immune complex nephritis in which the
antigen is repetitively administered for up to six weeks. The
variables of animal age, antigen dose, and level of immune
response were evaluated in mice deficient in CS and their
normal congenic pair. Young NSN mice with low titers of
anti-HAF production developed mild proliferative glomerular
lesions, while OSN animals producing similar titers of anti-
HAF had no apparent morphologic abnormality. Young NSN
mice who mounted a high titer antibody response developed
severe proliferative, and frequently necrotizing and crescentic
glomerulonephritis. Young OSN mice producing comparable
amounts of anti-HAF had mild proliferative glomerular abnor-
malities or no lesion at all. In older mice in whom a large
immune response was invariably produced, profound inter-
strain differences in the morphologic expression of disease were
evident. NSN mice always had proliferative, necrotizing le-
sions, and most had crescentic nephritis. OSN glomeruli were
largely affected by expansion of the mesangial matrix with
immune complex material. Five of fifteen OSN mice had a more
severe lesion, but their glomeruli were marked by a relatively
greater increase in matrix expansion without the proliferative
CS
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Fig. 7. Electron micrograph qf a glomerulus from afimr to eight—month—old OSN given 4 mg HAF daily. There are massive mesangial electron
dense deposits that are extending into the juxtamesangial subendothelial zone. (x4,750).
response seen in NSN mice. The glomerular hypercellularity of
NSN mice was due 1:0 apparent mesangial cell proliferation and
mononuclear leukocyte infiltration, without the presence of
polymorphonuclear leukocytes. NSN mice frequently had
tubulointerstitial nephritis, while only a few OSN animals were
so affected.
The morphologic expression of disease activity was corre-
lated with impaired renal function. In Group Ta where histologic
damage was minimal, serum creatinine levels were no higher
than control mice. In the most severely diseased animals,
Group II, serum creatinine levels in NSN mice were signifi-
cantly greater than those in OSN animals. The degree of injury
defined by the morphological scoring system used in this study
was closely correlated with serum creatinines (r = 0.82).
We postulated that older mice, uniformly capable of a high
titered antibody response, would have a milder lesion if given
less antigen. Such milder disease would be, in some respects,
analogous to the mild disease seen in those young mice with low
anti-HAF production, which resulted in clear distinctions in
immune complex localization between NSN and OSN mice.
When five—month—old mice were given I mg HAF on alternate
days, rather than 4 mg/day, morphologic differences in NSN
and OSN mice were magnified, but no statistically significant
differences in immune complex localization could be discerned.
While neither NSN or OSN mice had glomerular lesions by
week two, only the NSN mice had proliferative and necrotizing
glomerular lesions by four weeks of immunization. The CS
deficient mouse glomeruli were histologically similar to control
animals.
The presence of CS is essential for the full expression of
injury in this model of immune complex induced glomerular
injury. Whether the differences between NSN and OSN mice
were due to the membranolytic or leukotactic properties of
complement [15] cannot be determined by our studies. How-
ever, since OSN mice are capable of complement cascade
activation up to the C3 step, the glomerular lesion observed in
NSN mice was not attributable to the formation of activated
complement components prior to the formation of C5. This is
further supported by the observation on immunofluorescence
microscopy of similar amounts of C3 in glomeruli of OSN and
NSN mice.
Under some conditions, C5 may play a role in immune
complex localization in tissue. In mice who produced a low titer
of anti-HAF, the absence of CS affected the localization of HAF
in glomeruli. OSN mice had trace amounts of HAF deposited in
glomeruli, while NSN mice had substantial antigen localization
Fig. 8. Tubulointerstitial injury, including tubular atrophy, hyaline and
ery:hrocyte casts, and interstitial mononuclear leukocyte infiltration, in
a four to eight—month--old NSN given 4 mg HAF daily for six weeks.
(x600, hematoxylin and eosin).
in mesangial regions. This effect may have had a role in the
development of the milder lesion observed in these young OSN
mice.
In older C5-deficient mice in whom a high titered immune
response was produced, large amounts of immune complex
material were observed in mesangial regions on light and
electron microscopy. In these mice it is possible that the
build-up of immune complex material seen in OSN mice was
due to the inability of C5 deficient mice to solubilize previously
deposited immune complex material. Bartolotti and Peter [16]
have demonstrated that decomplemented rabbits given acute
immune complex nephritis have a significant decrease in their
rate of clearance of glomerular bound antigen and C3. Our
studies raise the possibility of a role for terminal complement
components in this solubilization process. Alternatively, larger
areas of glomerular acellular immune deposits in OSN mice
could be due to the absence of infiltrating leukocytes and
resultant diminished degradation of the deposits. The fact that a
few of the Group II OSN mice did have severe glomerular
lesions suggests that proximal complement components or
•1 I I I
1 2 3 4 5 6 7 8
Composite glomerular and tubulointerstitial score
Fig. 9. The serum creatinines were measured in Group II NSN and
OSN mice. A significantly higher level of serum creatinine was seen in
NSN (•) than OSN mice (0) (P < 0.05). When these creatinines were
compared with a composite morphologic score obtained by adding the
glomerular and tubular scores, a close linear relationship was observed
(r 0.82).
non-complement mediators of injury must also be playing a role
in this model of glomerulonephritis.
In conclusion, C5, or some other terminal complement com-
ponent(s) dependent upon C5 for activation play a pivotal role
in the morphologic expression of glomerular injury and impair-
ment of renal function in this model of heterologous pro-
tein—induced murine glomerulonephritis.
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